Press Releases

Strategic Vision – Optimal Value

Investor Presentation

Cronos Group News

Cronos Group Responds to Health Canada Testing

Cronos Group Responds to Health Canada Testing

TORONTO, May 5, 2017 /CNW/ - Cronos Group Inc.'s (TSXV:MJN) wholly owned licensed producer, the Peace Naturals Project Inc. ("Peace"), was notified on May 4, 2017 by Health Canada that upon testing a random cannabis leaf sample, trace levels of Piperonyl Butoxide...

read more
Cronos Group Provides Update on Minority Investments

Cronos Group Provides Update on Minority Investments

TORONTO, ON--(Marketwired - April 24, 2017) Cronos Group Inc. (formerly PharmaCan Capital Corp.) (TSX VENTURE: MJN) ("Cronos", or the "Company") is providing an update on its investments in Whistler Medical Marijuana Corporation ("Whistler"), The Hydropothecary...

read more
Cronos Recognized as Top TSX Venture 50 Performer

Cronos Recognized as Top TSX Venture 50 Performer

TORONTO, Feb. 27, 2017 /CNW/ - Cronos Group Inc., formerly PharmaCan Capital Corp., (TSX VENTURE: MJN) ("Cronos Group" or "the Company"), is excited to announce the Company's recent recognition as the top performer in the 2017 TSX Venture 50, an award reserved for the...

read more
PharmaCan Capital Announces $15 Million Bought Deal

PharmaCan Capital Announces $15 Million Bought Deal

TORONTO, ONTARIO--(Marketwired - Feb. 14, 2017) - NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES PharmaCan Capital Corp., doing business as Cronos Group (TSX VENTURE:MJN) ("Cronos" or the "Company") is pleased to...

read more
Cronos Calls Shareholder Meeting to Formalize Name Change

Cronos Calls Shareholder Meeting to Formalize Name Change

TORONTO, ON--(Marketwired - January 23, 2017) PharmaCan Capital Corp., doing business as Cronos Group (TSX VENTURE: MJN) ("Cronos" or the "Company"), seeks shareholder approval to formally change its name to "Cronos Group Inc." following the corporate rebranding...

read more
Cronos Group Granted Second Health Canada Sales License

Cronos Group Granted Second Health Canada Sales License

TORONTO, ON--(Marketwired - January 11, 2017) - NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH UNITED STATES NEWSWIRE PharmaCan Capital Corp., doing business as Cronos Group (TSX VENTURE: MJN) ("Cronos" or the "Company"), is pleased to announce that the...

read more

76 Stafford Street, Suite 302

Toronto, Ontario M6J 2S1

Info@TheCronosGroup.com
Careers@TheCronosGroup.com

(416) 504-0004